Page last updated: 2024-08-24

thiazolyl blue and Carcinoma, Neuroendocrine

thiazolyl blue has been researched along with Carcinoma, Neuroendocrine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sabra, MM; Sherman, EJ; Tuttle, RM; Yeh, T; Yeung, M1

Other Studies

1 other study(ies) available for thiazolyl blue and Carcinoma, Neuroendocrine

ArticleYear
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
    Thyroid : official journal of the American Thyroid Association, 2020, Volume: 30, Issue:8

    Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Disease Progression; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Prognosis; Retrospective Studies; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2020